Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)

TipRanksDec 15 10:50 ET · Ratings

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

PR NewswireDec 9 07:00 ET

BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

PR NewswireDec 3 07:00 ET

BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024

PR NewswireDec 2 07:00 ET

Express News | Brainstorm Cell Q3 2024 GAAP EPS $(0.51) Beats $(0.57) Estimate

BenzingaNov 14 17:23 ET

Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

SECNov 14 16:51 ET